USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ProFishent, Inc.
Address:
17806 NE 26TH ST
Redmond, WA 98052-5848
Phone:
(425) 883-9896
URL:
N/A
EIN:
912025622
DUNS:
179038190
Number of Employees:
3
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $369,651.00 5
SBIR Phase II $938,674.00 4

Award List:

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$49,000.00
Agency:
DOC
Principal Investigator:
David B. Powell, Principal Investigator
Abstract:
N/a

Cryopreservation and Lyophilization of Live Vaccines for Aquaculture

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$173,000.00
Agency:
DOC
Principal Investigator:
David B. Powell, Principal Investigator
Abstract:
N/a

A New Generation of Anti-viral Vaccines for Aquaculture Using Nanotechnology

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$49,820.00
Agency:
DOC
Principal Investigator:
David B. Powell, Vice President
Abstract:
This innovative Phase 1 project will test the feasibility of using the science of nanotechnology and emulsion chemistry to produce nanoparticles in a matrix to greatly enhance the immunogenicity of inactivated viruses. This new approach promises to have direct application to the development of… More

A New Generation of Anti-Viral Vaccines for Aquaculture Using Nanotechnology

Award Year / Program / Phase:
2004 / SBIR / Phase II
Award Amount:
$197,855.00
Agency:
DOC
Principal Investigator:
Abstract:
Although companies based outside the U.S. have tested and, in some cases, sold basic anti-viral vaccines to aquaculture producers, practicing veterinarians and virologists have been unimpressed by their extremely limited effectiveness (J. Mullins, pers. comm. 2002; J. Winton, pers. comm. 2004). The… More

Nanotechnology Systems to Prevent Disease and Improve Healing of Aquatic Animals

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$88,534.00
Agency:
DOC
Principal Investigator:
David B. Powell, Vice President, R & D
Abstract:
Netting, tagging, and/or vaccination of shrimp or fish often result in increased stress and infections caused by opportunistic pathogens. Damaged epidermis or cuticle provides a portal of entry to potentially deadly infective agents that bind preferentially to injured cells. Recent advances in… More

Natural Adjuvants to enhance Efficacy of Viral Vaccines for Mariculture

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$92,716.00
Agency:
DOC
Principal Investigator:
David B. Powell, Vice President, R & D
Abstract:
Viral diseases are a major impediment to the development and expansion of environmentally safe and sustainable aquaculture systems (NMFS 2007). Despite control measures, pathogenic viruses kill millions of fish and shellfish every year (ICES Mariculture Committee 2004). To date, vaccines… More

Micro-encapsulation and Nanotechnology Treatments to Prevent Proteolytic Diseases of Aquatic Animals

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$89,581.00
Agency:
USDA
Principal Investigator:
David B. Powell, Vice President
Abstract:
Although aquaculture is the world's fastest-growing animal food production system, diseases remain a major impediment to the development and expansion of environmentally safe and sustainable aquaculture in the United States. Pathogenic fungal and bacterial infections of eggs, skin, and gills… More

Natural Adjuvants to Enhance Efficacy of Viral Vaccines for Mariculture

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$298,427.00
Agency / Branch:
DOC / NOAA
Principal Investigator:
David B. Powell, VP, Research and Development – (425) 883-9896
Abstract:
Marine aquaculture production now exceeds 20 million metric tons annually (FAO 2010) but viral diseases are still a major threat to the expansion of sustainable mariculture systems (National Marine Fisheries Service 2007). Pathogenic viruses continue to devastate many fish and shellfish operations… More

Micro-encapsulation and Nanotechnology Treatments to Prevent Proteolytic Diseases of Aquatic Animals

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$269,392.00
Agency:
USDA
Principal Investigator:
David B. Powell, Vice President of Research – 425-883-9896
Abstract:
Many fungal and bacterial pathogens produce proteolytic enzymes that facilitate penetration into fish skin or eggshells. These diseases are a major and growing challenge to sustainable aquaculture in the United States. Our Phase I research results demonstrated the feasibility of new, non-toxic,… More